Latest Dilution News

Page 17 of 323
McDonald’s delivered higher profit and systemwide sales in the third quarter, helped by international markets, franchise margins and other operating income. The slight decline in US comparable sales remains the clearest test of whether its value push can restore guest traffic.
Logan Eniac
Logan Eniac
4 Nov 2026
Insulet delivered a stronger-than-expected third quarter, with revenue up 19.2% and adjusted earnings per share rising nearly 60%. The diabetes-device maker also raised its operating-margin outlook and authorised a US$1 billion share repurchase programme.
Ada Torres
Ada Torres
4 Nov 2026
Kraft Heinz reported falling third-quarter sales, profit and volumes, but raised the low end of its full-year organic sales outlook. The company also lifted its adjusted EPS range while leaving its sharply lower adjusted operating income forecast unchanged.
Victor Sage
Victor Sage
4 Nov 2026
Cencora delivered a stronger fiscal 2026, with adjusted earnings per share rising 12.3% and quarterly profit benefiting from the OneOncology acquisition. The healthcare distributor expects another 8% to 10% increase in adjusted EPS in fiscal 2027, while reshaping its reporting structure and lifting its dividend.
Ada Torres
Ada Torres
4 Nov 2026
CVS Health plans to separate its healthcare solutions and retail pharmacy businesses by the first half of 2028, while raising its 2026 earnings and cash-flow targets. The announcement came alongside stronger third-quarter results, though management flagged elevated cost trends and potential macroeconomic pressure.
Ada Torres
Ada Torres
4 Nov 2026
Zimmer Biomet lifted its full-year 2026 sales and adjusted earnings guidance after third-quarter constant-currency growth accelerated to 3.7%. The result was supported by strong hips, sports medicine and technology sales, although GAAP earnings fell and knees remained a weak spot.
Ada Torres
Ada Torres
4 Nov 2026
Estée Lauder has set a fiscal 2030 ambition of mid-single-digit organic sales growth, an adjusted operating margin of 16.5% to 18.5%, and double-digit adjusted EPS growth. The company also raised its fiscal 2027 outlook after a strong first quarter, while flagging the execution and adjustment risks behind its long-range targets.
Victor Sage
Victor Sage
4 Nov 2026
Stanley Black & Decker raised its 2026 earnings and free cash flow guidance after tariff refunds helped drive a sharp third-quarter profit recovery. Underlying organic growth improved, but the refund accounted for a substantial portion of the quarter’s earnings lift.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Qnity delivered 22% year-on-year growth in third-quarter sales and adjusted EPS, then raised its full-year 2026 targets. The result was strong operationally, although GAAP profit and reported EPS fell as transformation and IT independence costs weighed on the quarter.
Victor Sage
Victor Sage
4 Nov 2026
Alara Resources has received its first dividend from its Oman copper subsidiary, providing A$3.78 million in non-dilutive cash after a record quarter of concentrate shipments. The payment gives the parent company room to fund exploration, reduce debt and support working capital without immediately issuing shares.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Ocean Sciences has secured firm commitments for a $700,000 placement to fund its Indonesian seaweed operations, innovation centre and research pipeline. The raising comes with a substantial package of options, while a further loyalty offer could add to the company’s future capital structure.
Victor Sage
Victor Sage
4 Nov 2026
Pathkey.AI says an independent expert used its Chipforge platform to turn written specifications into working FPGA hardware without assistance from the company or manual code changes. The validation comes as Chipforge moves into pre-production customer work, but 88.5 million performance rights will also vest and the company’s benchmark comparisons remain internally generated.
Sophie Babbage
Sophie Babbage
4 Nov 2026

Browse the archive

Full archive